Cathy S. Madsen - Concepedia

Author

Cathy S. Madsen

Mayo Clinic in Arizona

Also Known As

C MADSEN, C.S. Madsen, Cathy Madsen, Cathy S Madsen, Cathy S. Madsen

Publications

988

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic in Arizona Arizona State University Mayo Clinic University of Georgia WinnMed

About

Cathy S. Madsen is an author at Mayo Clinic in Arizona specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	136
2	Health Sciences	2	2	74
3	Natural Sciences	2	2	74
4	Biochemistry	2	2	74
5	Biology	1	1	10

Cathy S. Madsen

Publications

970

Citations

H-Index

Page 1

	Year	Citations
Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine Vani Lakshminarayanan, Pamela Thompson, Margreet A. Wolfert, Proceedings of the National Academy of Sciences	2011	298
Mice with Spontaneous Pancreatic Cancer Naturally Develop MUC-1-Specific CTLs That Eradicate Tumors When Adoptively Transferred Pinku Mukherjee, Amelia R. Ginardi, Cathy S. Madsen, The Journal of Immunology	2000	89
Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer. Pinku Mukherjee, Cathy S. Madsen, Amelia R. Ginardi, Journal of Immunotherapy	2003	87
Mucin mRNA Expression in Normal and Vasomotor Inferior Turbinates Michelle R. Aust, Cathy S. Madsen, Anita Jennings, American Journal of Rhinology	1997	76
Modified EPR spectra of the tyrosineD radical in photosystem II in site-directed mutants of Synechocystis sp. PCC 6803: Identification of side chains in the immediate vicinity of tyrosineD on the D2 protein Cecilia Tommos, Bengt Svensson, Cathy S. Madsen, Biochemistry Altmetric Attention ScoreMolecular BiologyMolecular ResearchPhototropinPcc 6803	1993	64
MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironment Pinku Mukherjee, Amelia R. Ginardi, Cathy S. Madsen, Glycoconjugate Journal	2001	64
MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice Vani Lakshminarayanan, Nitin T. Supekar, Jie Wei, PLoS ONE	2016	51
Muc1 is protective during kidney ischemia-reperfusion injury Núria M. Pastor‐Soler, Timothy A. Sutton, Henry Mang, American Journal of Physiology-Renal Physiology Mouse Mucin 1Human Mucin 1Renal PathologyRenal InflammationCellular Physiology	2015	43
Muc1 enhances the β-catenin protective pathway during ischemia-reperfusion injury Mohammad M. Al‐bataineh, Carol L. Kinlough, Paul A. Poland, American Journal of Physiology-Renal Physiology Renal InflammationCellular PhysiologyOxidative StressInflammationRenal Function	2016	30
Brain specific autoantibodies in murine models of systemic lupus erythematosus Steven A. Hoffman, Cathy S. Madsen Journal of Neuroimmunology Autoimmune DiseaseSystemic Lupus ErythematosusAutoantibody ProductionLupusMedicine	1990	29

Page 1